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Abstract
Purpose. This study was performed to demonstrate that the results obtained with a 
calibration phantom could be used as a tool for standardizing measurement of heart-to-
mediastinum (H/M) ratio in cardiac metaiodobenzylguanidine (MIBG) imaging.
Method. Images of the phantom containing 123I-MIBG were acquired on the cameras in 10 
hospitals (11 camera types) to determine the relationship between H/M ratios using different 
collimators: low energy (LE) and medium-energy (ME)/low-medium-energy (LME) 
collimators. The effect of standardization to the ME-comparable H/M ratio was examined in 
two settings: a Japanese standard MIBG database (n=62) and multi-center studies (n=49). In a 
multi-center study, probable Alzheimer disease (AD, n=18) and probable dementia with Lewy 
bodies (DLB, n=31) were studied and standardized by the calibration phantom method. 
2Results. Linear regression equations between LE and ME collimators were obtained for the 
phantom study in all institutions. When the H/M ratio with a LE collimator was corrected 
based upon the calibration phantom, the corrected values were comparable to those 
obtained using ME collimators. The standard database also exhibited a normal distribution 
after standardization as determined by skewness and goodness-of-fit test. A mixture of the 
populations by LE and ME collimators showed significant separation of AD and DLB groups 
(F ratio=24.9 for the late H/M), but the corrected values resulted in higher F ratios for both 
early and late H/M (F ratio= 34.9 for the late H/M).
Conclusion. Standardization of H/M ratios by the heart-chest calibration phantom method 
is feasible among different collimator types. This method could be practically used for 
multicenter comparison of H/M ratios.




 123I-metaiodobenzylguanidine (MIBG) has been used extensively in fields of cardiology 
and neurology as a unique imaging method to evaluate sympathetic nerve activity and its 
integrity [1-7]. Inter-institutional differences in MIBG quantification using the heart-to-
mediastinum ratio (H/M) have hampered multi-center comparison of the H/M ratio, and 
single-center results could not easily be extrapolated to other hospitals [8]. Since the 
difference in collimator type has been investigated and found to be one of the major 




 In neurological studies, patients with Parkinson disease and dementia with Lewy 
bodies (DLB), which is categorized as Lewy-body disease demonstrated significantly lower H/
M ratios both in early and late imaging [4-7]. Since the patients with Lewy-body disease 
showed lower H/M values compared with those of normal populations, we used this patient 
group for a pilot study of the procedure for correction of H/M ratios. In addition, since a 
multi-center study including DLB and MIBG imaging has started in Japan, an appropriate 
correction method was indispensable to overcome the variation of normal values among 
participating hospitals. The aim of our study was to standardize the MIBG H/M ratio using a 
calibration method and examine the effect of this correction on pilot studies. The method 
was applied to two settings: (1) MIBG normal databases created by a Japanese Society of 
Nuclear Medicine (JSNM) working group and (2) the multicenter study examining 




 MIBG studies were performed as a research procedure, with images acquired at 20 
minutes and 180 minutes after intravenous injection of 111 MBq of 123I-MIBG. Early and late 
images were obtained by both anterior planar image and single-photon emission tomography 
(SPECT). Planar images were obtained in 256 x 256 matrices, and acquisition time was 180 
seconds. The energy for 123I was centered at 159 keV with a window of 20%. Only the planar 




 The calibration phantom for 123I-MIBG was used as previously described [11, 13]. 
Briefly, the phantom was made for a planar-image acquisition and consisted of multiple slices 
of heart, lung, mediastinum and liver parts. All the parts were filled with radioisotope as a 
single compartment, so that no adjustment of 123I concentration in each organ part was 
required. In this study, two types of phantom were used to calculate 4 sets of H/M ratios. 
True H/M ratios were mathematically calculated in these models, assuming the linear 
attenuation coefficient of 123I for water as 0.147/cm. The theoretical values were 2.60 and 
3.50 for one type and 1.55 and 1.80 for the other type using anterior and posterior views 
[11]. The calibration phantom and a typical image are shown in Figure 1. The H/M values using 
ME collimators were used as the reference for the study.
Calculation of H/M ratios
	
 In the clinical and phantom studies, a semi-automatic algorithm for determining 
mediastinal region of interest (ROI) was used [14]. After manually setting a circular ROI on 
the center of the heart, a mediastinal rectangular ROI was automatically determined on the 




Participating hospitals for the phantom study
	
 The phantom acquisitions on each camera were performed with the two different 
collimators. Ten hospitals participated in the phantom study (see acknowledgment section of 
participating hospitals). The anterior images of the phantom were obtained with both low-
energy (LE) collimator and either a low-medium-energy (LME) or medium-energy (ME) 
collimators. The phantom was filled with water, including 111MBq of 123I-MIBG. The anterior 
and posterior images were obtained using 256 x 256 matrices for 3 minutes. All the data 
were transferred to Kanazawa University with a Digital Imaging and Communication in 
Medicine (DICOM) format for evaluating the correction method.
	
 Eleven gamma-camera systems were used for MIBG studies in ten institutions (Table 
1). The H/M ratio was corrected using a regression equation between LE- and ME-type 
collimators which was determined by the calibration phantom. Since four points were given 
by the phantom experiment, a linear regression equation of (y-1)=slope*(x-1) was also 
calculated by the least square fitting method. As this regression line passes through (x, y)=(1, 
1), the corrected and uncorrected H/M ratios always become 1 when cardiac count is equal 
to mediastinal count. The H/M values from the ME collimator were used as the standards, 
since the ME-collimator type is known to provide a minimal variation [12]. 
JSNM working group database
	
 The JSNM working group for standardization of myocardial SPECT has accumulated 
MIBG normal databases of early and late anterior images and SPECT [15, 16]. The selection 
criteria of the normal databases involved patients who had none of the following conditions: 
electrocardiographic evidence of myocardial ischemia, baseline cardiac diseases (including 
coronary artery disease, valvular heart disease and severe arrhythmia), history of heart 
failure, severe liver dysfunction, renal dysfunction, history of heart failure, hypertension with 
medication, diabetes with medication and dyslipidemia with medication. Those who had 
coronary stenosis of <50% and those who had no indications for coronary angiography could 
be included if the criteria above were satisfied. The databases consisted of 37 (16 men and 21 
4women) using the LE collimator and 25 (12 men and 13 women) with the LME or ME 
collimator. The average age was 57 ± 19 years old. The correction of the H/M ratio with the 
LE collimator using the calibration phantom method was examined.
Multi-center study
	
 To evaluate the effect of standardization in multiple institutions, patients suspected of 
having AD and DLB were selected for this comparative study. The diagnosis was 
independently performed by neurology specialists. General physical and neurologic 
examinations, neuropsychological evaluations and appropriate laboratory studies were 
conducted to confirm the accuracy of the clinical diagnosis. The diagnosis of AD was made in 
accordance with the National Institute of Neurological and Communicative Disorders and 
Stroke and the Alzheimer’s Disease and Related Disorders Association [17]. The diagnosis of 
DLB was made in accordance with DLB consensus criteria [18]. In probable AD patients 
(n=18, age 75±8 years), 11 patients were studied using an LE collimator and 7 using an LME 
collimator. In probable DLB patients (n=31, age 79±5 years), 16 patients were studied using 
an LE collimator and 15 using an LME collimator. The standardized H/M ratio was calculated 
by the calibration phantom method.
Institutional Review Board
	
 To accumulate the patient clinical data and the results of nuclear imaging, all 
Institutional Review Boards or Ethical Committees approved the study for conducting the 
MIBG research and transferring the DICOM image data to the core laboratory. Written 
informed consents were obtained from all patients. The use of JSNM databases was approved 
by the working group.
Statistics
	
 All data were expressed as an average ± standard deviation (SD). The values were 
compared with analysis of variances (ANOVA) and T test using statistical software (JMP 8.0, 
SAS institute, Inc). The regression line of H/M ratios between measurements was calculated 
by the least square fitting method. Regarding the asymmetry of distribution, median, quartile 
points and skewness were used. A positive skew indicates that right tail is longer, and mass of 
the distribution is concentrated on the lower values. The fitness to normal distribution was 





 H/M ratios calculated with LE and ME collimators are plotted in Figure 2. In all 
hospitals, the H/M ratio calculated with LE collimators showed lower values than those with 
ME collimators, and a linear relationship between both methods was observed. The linear 
regression line between methods with LE and ME collimators differed slightly based on 
camera types used in each hospital. However, the average regression line was y = 0.460 + 
0.646 x, where x and y were H/M ratios calculated by ME and LE collimators, respectively, 
whereas when it was calculated to pass through the point (1,1), the line was y-1 = 0.719 
(x-1). In each institution the corrected H/M ratios from LE to ME-comparable values were 
calculated by the individual institutional regression line, not by the average regression line.  
JSNM working group database
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 The distribution histogram of the normal database is shown in Fig. 3. The average H/M 
ratio from the LE collimator was significantly lower than that from the LME/ME collimators 
(p<0.0001 for early and late H/M ratios). When these two groups were mixed (Fig. 3B), the 
distribution became asymmetric showing low median values. After the correction of H/M 
ratios with the LE collimator using the phantom method, the histogram shape became 
symmetrical in comparison to that of normal distribution. The skewness improved from 0.89 
to 0.02 for the early H/M ratio, and from 1.28 to 0.44 for the late H/M ratio. When the 
Shapiro-Wilk goodness-of-fit test was applied, the uncorrected H/M ratios were not 
normally distributed (p=0.014 and 0.0003 for the early and late H/M ratios). In contrast the 
corrected H/M ratios showed normal distribution (p=0.97 and 0.42 for the early and late H/
M ratios). The average values after standardization did not differ significantly from those with 
LME/ME collimators (3.05±0.42 and 3.01±0.53, respectively, p=n. s.).
Multi-center study
	
 Patients with probable DLB showed lower H/M ratios than those with probable AD 
regardless of collimator selection (Table 2). Mixed H/M ratios with LE and LME collimators 
showed significant differences between the AD and DLB groups (F ratio=20.4 and 24.9 for 
early and late H/M ratios). However, when the H/M ratio was corrected by the calibration 
phantom method, the F ratio increased to 31.7 and 34.9 for the early and late H/M ratios, 
respectively (p<0.0001 for all). When the skewness of the distribution of the H/M ratio was 
anlayzed in the probable AD patients, it improved from 0.60 to -0.003 in the early H/M ratio 
and from 0.87 to 0.02 in the delayed H/M ratio after standardization. The changes of 
skewness implied more even or symmetric distributions after standardization. The effect of 
correction was more significant in the probable AD group, as the DLB patients showed 
significantly lower values near 1.0.
Discussion
	
 The need for standardization of MIBG quantification has been discussed particularly 
from the viewpoint of inter-institutional comparison and multi-center studies. Although 
several ideas have been proposed, practical solutions acceptable to all institutions have not 
been proposed [8, 19]. The present study demonstrated that the calibration phantom method 
could provide a similar linear relationship between LE and LME/ME collimators in 10 
institutions and that it could be applied to different camera-collimator systems. After mixing 
H/M ratios by different camera-collimator settings, the standardization provided more 
uniform distribution as determined by skewness and goodness-of-fit test to the normal 
distribution.
	
 123I-MIBG imaging has been extensively used in patients with ischemic heart disease 
and heart failure [1, 2, 20-22]. MIBG imaging was approved by the Japanese Circulation 
Society in its guidelines, and the indications were classified into Class I (evidence and/or 
general agreement) and Class IIa (weight of evidence is in favor) [23]. In most of the studies, 
the quantification of cardiac MIBG activity was based on a simple ROI setting on the heart 
and mediastinum. In the recent ADMIRE-HF study, patients with a low H/M ratio showed a 
significantly higher incidence of serious cardiac events including progression of heart failure, 
serious arrhythmia and cardiac death [21]. 
	
 We selected patient groups with Lewy bodies as a pilot study, since they have 
pathological background of decreased MIBG uptake [5, 6]. The myocardial MIBG defects 
reflected a pathological progression of the disease process involving extensive autonomic 
6involvement, not restricted to the brain. In this study, AD patients showed a significantly 
higher H/M ratio than that of the DLB patients, but these values were lower than that of the 
normal H/M ratio calculated with JSNM normal databases. Since the age of AD patients was 
higher than that of the JSNM normal patients, the effect of age-related change (average age, 
75±8 vs. 57±19 years old) and complicated diseases might partly explain the difference in the 
H/M ratios [24].
	
 The effects of collimator selection have been evaluated, and a number of studies have 
indicated that H/M ratios with the LE collimator showed a lower value compared to that 
with the ME collimator [9-12, 19]. Verberne et al. found that the collimator type was one of 
the independent predictors of late H/M for subjects with a late H/M 1.4– 2.0. Normal values 
assembled by the different types of collimators showed significant differences in Japanese 
standard MIBG databases: 2.39±0.21 and 2.49±0.25 for early and late imaging using an LE 
collimator, and 2.76±0.31 and 3.01±0.35 using an ME collimator, respectively (p<0.0001 for 
both early and late H/M ratios) [15, 16]. While several methods to overcome collimator 
differences have been proposed [11, 25], a European group recommended the use of ME-type 
collimators as a standard procedure based on a phantom study [10]. However, we examined 
the calibration phantom approach in this study, since the idea of cross-calibration among 
nuclear medicine systems was supposed to be straight-forward and applicable to any 
institution.
	
 After the standardization of normal databases, the mixture of H/M ratios by LE and 
ME collimators became a normal distribution. The use of single normal value would be 
convenient for clinical practice. In patients with abnormal MIBG studies, a mixture of H/M 
values from cameras with the LE, LME and ME types of collimators may have resulted in 
potentially low diagnostic ability. Since the H/M ratio was apparently low in patients with 
Lewy-body disease, separation between Lewy-body disease and near-normal MIBG patients 
was only slightly affected by the correction in this study. However, in patients with heart 
failure and in non-heart failure groups, the H/M ratios may not have been clearly separated, 
showing continuous distributions with an overlapped zone. Since the separation of two 
groups depends on their average and deviation, whether diagnostic accuracy was enhanced 
by the standardization should be carefully interpreted. We presumed a mixture of H/M ratios 
using two types of collimators in this study.  Although identical acquisition parameters should 
be decided in the research purpose, differences in collimator designs still existed depending 
on camera venders even with similar collimator types, such as LEHR, LEGP and other special 
LE types covering 123I energy [9, 10]. 
	
 Some limitations are described. The standardization proposed in this study was not to 
create theoretically true or scatter- and septal-penetration-free images. It only provided an 
ME-collimator comparable H/M value, since the use of the ME collimator minimized the 
septal penetration among currently available collimators [12]. Although the recommendation 
to use ME-type collimators is a reasonable approach, many institutions continue to use LE-
type collimators because of collimator availability and the inconvenience of changing 
collimators from study to study in daily practice. The calibration phantom was created for 
planar studies and could not be used for SPECT studies. However, to calibrate anterior 
images from septal penetration and partly from Compton scatter, the use of phantom 
calibration seemed to be a practical method. Although H/M ratios from ME and LME 
collimators showed similar values in our camera-collimator setting [11], those from other 
camera venders may differ significantly. The difference in LME and ME collimators, if present, 
would be also confirmed by the calibration phantom. 
7Conclusion
	
 123I-MIBG H/M ratios measured by an LE collimator were corrected to ME collimator-
comparable values using a calibration phantom. In normal databases the correction method 
provided comparable values between the use of LE- and LME/ME-type collimators, resulting 
in normal distribution of H/M ratios. Although a mixture of LE and ME collimator data in AD 
and DLB groups could be separated even before correction, this correction method provided 
a better separation of the two groups. When gathering MIBG studies as a multi-center study, 
the calibration phantom method can be readily applied in all hospitals, and it would 
potentially enhance diagnostic ability.
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8Table 1. Scinticamera venders and collimator types in 10 institutions
institution camera vender LE types ME types Routine study
A Toshiba LE HR LME GP ME
B1* Shimadzu LE GP ME GP LE
B2* Siemens LE HR ME LE
C Siemens LE HR ME LE
D Toshiba LE HR LME GP ME
E Philips LE HR ME GAP LE
F Siemens LE HR LME GP LE
G Siemens LE HR LME GP ME
H GE ELE GP ME LE
I Siemens LE HR ME LE
J Shimadzu LE HR ME LE
ME, medium energy; LE, low energy; HR, high resolution; GP, general purpose; ELE, extended 
low-energy; LME, low-medium-energy; GAP, general all purpose; Nomenclatures of the 
collimator type depending on the venders; * Institution B uses two scinticameras.
Table 2. Comparison of H/M ratios between Alzheimer disease and 
dementia with Lewy bodies
AD DLB ANOVA
n mean±SD n mean±SD F ratio p
Early H/M
No correction
   H/M with LE 11 2.10±0.28 16 1.48±0.28 30.8 <0.0001
   H/M with LME 7 2.68±0.52 15 1.87±0.60 9.5 0.0059
   Mixed H/M with LE and LME 18 2.33±0.48 31 1.67±0.50 20.4 <0.0001
Standardized H/M with LE and ME 
   18 2.55±0.40 31 1.76±0.51 31.7 <0.0001
Late H/M
No correction
   H/M with LE 11 2.09±0.26 16 1.31±0.31 45.8 <0.0001
   H/M with LME 7 2.69±0.75 15 1.64±0.74 9.4 0.0060
   Mixed H/M with LE and LME 18 2.32±0.57 31 1.47±0.57 24.9 <0.0001
Standardized H/M with LE and ME
18 2.55±0.53 31 1.54±0.60 34.9 <0.0001




 123I-MIBG calibration phantom (left) and a typical scintigraphic image (right).
Figure 2
	
 Relationship of H/M ratios obtained from 10 hospitals (11 camera types). H/M ratios 




 Histograms of normal patients from JSNM working group databases. (A) Early and late 
H/M ratios without correction. (B) Distribution of H/M ratios when LE and LME/ME groups 
were mixed. (C) Distribution of H/M ratios when those from LE collimator are corrected by 
the calibration phantom method. After the standardization, the distribution became normal. 
The skewness was 0.89 and 1.28 in B, and 0.02 and 0.44 in C for the early and late H/M 
ratios, respectively. The outlier box plot indicates median and 25 and 75% quartiles. 
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